Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

Chan, 2020, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet, 395, 514, 10.1016/S0140-6736(20)30154-9

Chan, 2015, Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease, Clin Microbiol Rev, 28, 465, 10.1128/CMR.00102-14

Cheng, 2007, Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection, Clin Microbiol Rev, 20, 660, 10.1128/CMR.00023-07

Peiris, 2003, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet, 361, 1767, 10.1016/S0140-6736(03)13412-5

Chu, 2004, Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings, Thorax, 59, 252, 10.1136/thorax.2003.012658

To, 2020, Consistent detection of 2019 novel coronavirus in saliva, Clin Infect Dis, 10.1093/cid/ciaa149

Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 10.1038/s41586-020-2951-z

Zou, 2020, SARS-CoV-2 viral load in upper respiratory specimens of infected patients, N Engl J Med, 10.1056/NEJMc2001737

To, 2019, Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study, Clin Microbiol Infect, 25, 372, 10.1016/j.cmi.2018.06.009

To, 2019, Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study, Clin Microbiol Infect, 25, 1539, 10.1016/j.cmi.2019.04.012

To, 2017, Additional molecular testing of saliva specimens improves the detection of respiratory viruses, Emerg Microbes Infect, 6, e49, 10.1038/emi.2017.35

Chan, 2020, Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens, J Clin Microbiol, 10.1128/JCM.00310-20

Woo, 2004, Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia, Lancet, 363, 841, 10.1016/S0140-6736(04)15729-2

Chen, 2019, Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains, Epidemiol Infect, 147, e279, 10.1017/S0950268819001717

Chan, 2005, Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63, Clin Diagn Lab Immunol, 12, 1317, 10.1128/CDLI.12.11.1317-1321.2005

Oh, 2016, Viral load kinetics of MERS coronavirus infection, N Engl J Med, 375, 1303, 10.1056/NEJMc1511695

Hayden, 1999, Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment, JAMA, 282, 1240, 10.1001/jama.282.13.1240

Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 10.1001/jama.2020.1585

Hung, 2017, Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: an open-label randomized, controlled, phase IIb/III trial, Chest, 151, 1069, 10.1016/j.chest.2016.11.012

Chan, 2015, Treatment With lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset, J Infect Dis, 212, 1904, 10.1093/infdis/jiv392

Nukoolkarn, 2008, Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors, J Theor Biol, 254, 861, 10.1016/j.jtbi.2008.07.030

Chu, 2004, Initial viral load and the outcomes of SARS, CMAJ, 171, 1349, 10.1503/cmaj.1040398

Chen, 2006, Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms, Clin Infect Dis, 42, 1561, 10.1086/503843

Zhang, 2020, Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes, Emerg Microbes Infect, 9, 386, 10.1080/22221751.2020.1729071

Zhang, 2006, Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals, J Med Virol, 78, 1, 10.1002/jmv.20499

Liu, 2019, Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection, JCI Insight, 4, 10.1172/jci.insight.123158

Park, 2016, Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus, Cold Spring Harb Mol Case Stud, 2, 10.1101/mcs.a001214

Wang, 2004, Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis, Emerg Infect Dis, 10, 1213, 10.3201/eid1007.031113

Liu, 2011, Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques, J Virol, 85, 4025, 10.1128/JVI.02292-10

Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 10.1056/NEJMoa2002032

Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 565, 10.1016/S0140-6736(20)30251-8

Che, 2005, Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43, J Infect Dis, 191, 2033, 10.1086/430355